Cytokinetics, Incorporated

CYTK

$68.45

Name : Cytokinetics, Incorporated

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $9,293,496,320.00

EPSttm : -6.85

Cytokinetics, Incorporated

$68.45

0.81%

$0.55

CYTK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.82

Margin Of Safety %

Put/Call OI Ratio

0.33

EPS Next Q Diff

0.08

EPS Last/This Y

0.11

EPS This/Next Y

1.68

Price

68.39

Target Price

104.7

Analyst Recom

1.3

Performance Q

6.62

Upside

-449.7%

Beta

0.47

Ticker: CYTK

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	CYTK	74.84	0.46	0.13	149975
2026-05-12	CYTK	74.77	0.47	0.02	150520
2026-05-13	CYTK	77.22	0.45	0.59	153527
2026-05-14	CYTK	78.41	0.45	0.45	153207
2026-05-15	CYTK	75.85	0.44	0.06	152119
2026-05-18	CYTK	75.18	0.39	0.08	90335
2026-05-19	CYTK	76.46	0.39	0.43	90560
2026-05-20	CYTK	78.72	0.39	0.09	91334
2026-05-21	CYTK	78.07	0.38	0.04	93774
2026-05-22	CYTK	76.91	0.37	0.07	95749
2026-05-26	CYTK	76.31	0.37	0.21	97588
2026-05-27	CYTK	77.18	0.37	0.02	98628
2026-05-28	CYTK	76.82	0.36	0.52	100161
2026-05-29	CYTK	76.78	0.36	0.01	100517
2026-06-02	CYTK	70.9	0.34	0.07	104424
2026-06-03	CYTK	70.69	0.33	0.12	105769
2026-06-04	CYTK	72.09	0.34	1.04	105570
2026-06-05	CYTK	71.48	0.33	0.04	105452
2026-06-08	CYTK	67.9	0.33	0.22	105219
2026-06-09	CYTK	68.45	0.33	0.07	110774
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	CYTK	74.58	-47.6	-12.9	-6.70
2026-05-12	CYTK	74.76	-49.5	-35.5	-6.59
2026-05-13	CYTK	77.21	-50.4	-57.1	-6.59
2026-05-14	CYTK	78.64	-50.4	-96.8	-6.61
2026-05-15	CYTK	75.84	-50.4	-55.5	-6.61
2026-05-18	CYTK	75.16	-48.9	-75.8	-6.55
2026-05-19	CYTK	76.50	-48.9	-96.3	-6.55
2026-05-20	CYTK	78.72	-48.9	-105.4	-6.55
2026-05-21	CYTK	78.03	-46.5	-75.5	-6.55
2026-05-22	CYTK	76.92	-46.5	-71.6	-6.43
2026-05-26	CYTK	76.24	-46.5	-76.1	-6.43
2026-05-27	CYTK	77.18	-46.5	-91.5	-6.43
2026-05-28	CYTK	76.82	-46.5	-79.4	-6.43
2026-05-29	CYTK	76.76	-46.5	-82.1	-6.43
2026-06-01	CYTK	73.73	-46.5	-52.7	-6.43
2026-06-02	CYTK	70.79	-46.5	-52.2	-6.43
2026-06-03	CYTK	70.68	-46.5	-80.3	-6.43
2026-06-04	CYTK	72.29	-46.5	-100.0	-6.43
2026-06-05	CYTK	71.44	-46.5	-73.7	-6.43
2026-06-08	CYTK	67.90	-46.5	-44.5	-6.43
2026-06-09	CYTK	68.39	-46.5	-88.3	-6.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	CYTK	-9.61	-2.38	12.34
2026-05-12	CYTK	-9.66	-2.38	13.18
2026-05-13	CYTK	-9.55	-2.38	13.18
2026-05-14	CYTK	-9.55	-2.38	13.18
2026-05-15	CYTK	-9.71	-2.38	13.18
2026-05-18	CYTK	-9.71	-1.22	13.24
2026-05-19	CYTK	-8.56	-1.22	13.24
2026-05-20	CYTK	-8.53	-1.22	13.24
2026-05-21	CYTK	-8.53	-1.22	13.24
2026-05-22	CYTK	-8.53	-1.22	13.24
2026-05-26	CYTK	-8.53	5.75	13.34
2026-05-27	CYTK	-7.22	5.75	13.34
2026-05-28	CYTK	-7.22	5.75	13.81
2026-05-29	CYTK	-7.34	5.75	13.81
2026-06-02	CYTK	-7.72	4.96	13.82
2026-06-03	CYTK	-7.00	4.96	13.82
2026-06-04	CYTK	-7.00	4.96	13.82
2026-06-05	CYTK	-7.00	4.96	13.82
2026-06-08	CYTK	-6.13	5.00	13.82
2026-06-09	CYTK	-6.13	5.00	13.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.67

Avg. EPS Est. Current Quarter

-1.64

Avg. EPS Est. Next Quarter

-1.59

Insider Transactions

-6.13

Institutional Transactions

Beta

0.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-72.4

Target Price

104.7

P/E

Forward P/E

PEG

P/S

80.5

P/B

P/Free Cash Flow

EPS

-6.84

Average EPS Est. Cur. Y

-6.43

EPS Next Y. (Est.)

-4.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-784.02

Relative Volume

Return on Equity vs Sector %

72.9

Return on Equity vs Industry %

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.14

EBIT Estimation

-88.3

◆ CYTK Healthcare

$68.45

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

22/25

Volume

4/15

Valuation

9/20

TP/AR

4/10

Options

8/10

RSI

40.5

Range 1M

7.9%

Sup Dist

3.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

15/30

Estimates

3/20

Inst/Vol

8/15

Options

8/10

EPS Yr

2.4%

EPS NY

28.1%

52W%

74.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +53% upside

Quality

7/30

Valuation

10/30

Growth

11/25

Stability

9/10

LT Trend

0/5

Upside

+53%

Quality

Cytokinetics, Incorporated

Sector: Healthcare

Industry: Biotechnology

Employees: 673

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

CYTK

Latest News

—

Caricamento notizie per CYTK…

stock quote shares CYTK – Cytokinetics, Incorporated Stock Price stock today

news today CYTK – Cytokinetics, Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch CYTK – Cytokinetics, Incorporated yahoo finance google finance

stock history CYTK – Cytokinetics, Incorporated invest stock market

stock prices CYTK premarket after hours

ticker CYTK fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CYTK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y